Article

Pfizer Seeks OTC Switch for Lipitor

Does pharmacy benefit when widely-used prescription drugs go OTC, or does our profession benefit more when they go generic?

A recent news report mentioned that Pfizer was planning to request approval from the FDA to make Lipitor, the largest selling statin agent, to over-the-counter (OTC) status. It’s

interesting to note that Merck was unsuccessful when it tried to move Mevacor to OTC status before they lost the patent and it went generic (See Pharmacy Times’ full article).

Isn’t this an interesting development? Will Pfizer be more successful than Merck in trying to convert Mevacor to OTC status, perhaps because Lipitor has been used by so many statin users? Is Pfizer motivated more by dollars or the benefit to the patient? Does pharmacy benefit when widely-used prescription drugs go OTC—or does our profession benefit more when they go generic? Which is better for patients?

Please share your opinions.

Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com